Dr. Joerg Hipp is a biomarker and experimental medicine leader at F. Hoffmann-La Roche with a background in Neuroscience. Before joining Roche, his main research focus was to understand the role of neuronal oscillations in normal and pathological brain function using different techniques including EEG, MEG and fMRI. At Roche, he is responsible for the biomarker strategy and implementation in several drug development programs with a focus on neurodevelopmental disorders – including Angelman syndrome – and he heads the group Electrophysiology & Analytics, which provides translational support across the neuroscience portfolio (Publications: https://orcid.org/0000-0002-7875-2988).